Novartis AG
NVS
NYSE
Healthcare
$159.90
+3.74%gain today
Market position
Market cap rank
#43
Top 50
of 2,614
1-day
+3.74%
1-month
+11.44%
6-month
+15.98%
YTD
+15.42%
1-year
+29.15%
5-year
+84.51%
Key figures
Market cap
$305.1B
P/E (live)
22.1
price ÷ annual EPS
P/E (reported)
19.0
FY 2025
EPS
$7.25
FY 2025
Dividend yield
2.94%
FY 2025
Dividend / share
$4.74
Gross margin
75.02%
FY 2025
Operating margin
31.15%
FY 2025
Net margin
25.64%
FY 2025
Return on equity
—
FY 2025
Valuation & financial health
Enterprise value
$292.92B
FY 2025
EV / EBITDA
12.74
FY 2025
EV / Sales
5.34
FY 2025
Price / book
5.79
FY 2025
Price / sales
4.88
FY 2025
Earnings yield
5.26%
FY 2025
FCF yield
6.62%
FY 2025
Debt / equity
0.80
FY 2025
Current ratio
1.12
FY 2025
Return on assets
—
FY 2025
Return on invested capital
Financials · FY 2025
Revenue
$54.81B
Gross profit
$41.12B
Operating income
$17.07B
EBITDA
$22.99B
Net income
$14.06B
Diluted EPS
$7.19
Shares outstanding
1,938,950,000
Trading
Open
$157.50
Previous close
$154.14
Day range
$157.01 – $160.57
52-week range
$112.34 – $170.46
50-day avg
$149.43
200-day avg
$143.49
Volume
1,551,659
Avg volume
1,721,209
Beta
0.49
Price history
+29.15% over 1Y
Compare with peers
About Novartis AG
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Visit websiteCompany info
CEO
Vas Narasimhan
IPO date
Nov 7, 1996
Headquarters
Basel, BS, CH
Country
CH
Fundamentals are annual. Figures labeled with their fiscal year.
